Industries > Pharma > Biopharmaceuticals Excipients Market 2020-2030

Biopharmaceuticals Excipients Market 2020-2030

Triglycerides, Esters, Mannitol, Sorbitol, Sucrose, Dextrose, Starch, Specialty Biopharmaceutical Excipients & Others PLUS leading Biopharmaceuticals Excipients companies analysis

PUBLISHED: 15 April 2020
PAGES: 162
PRODUCT CODE: PHA0734

Clear
WOOCS 2.2.1

The biopharmaceuticals excipients market is expected to grow at a CAGR of 12.2%.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 162-page report you will receive 85 charts– all unavailable elsewhere.

The 162-page report provides clear detailed insight into the biopharmaceuticals excipients market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Biopharmaceuticals excipients market forecasts to 2030

• This report also breaks down the revenue forecast for the global pharmaceutical excipient market by product type (Solubilizers & Surfactants/Emulsifiers, Polyols, Carbohydrates, Speciality Biopharmaceutical Excipients)

• Solubilizers & Surfactants/Emulsifiers:
• Triglycerides
• Esters
• Others

• This report also breaks down the revenue forecast for the biopharmaceuticals excipients market by Polyols:
• Mannitol
• Sorbitol
• Others

• This report also breaks down the revenue forecast for the biopharmaceuticals excipients market by carbohydrates:
• Sucrose
• Dextrose
• Starch
• Others

• This report provides individual revenue forecasts to 2030 for these regional and national markets:
• North America: US and Canada
• Europe: UK, France, Germany, Spain, Italy, Rest of Europe
• APAC: China, India, Australia, Indonesia, South Korea, Rest of APAC
• MEA
• RoW

Biopharmaceuticals Excipients Market 2020-2030

Each region is further broken down by product type

• Our study gives a SWOT & PEST Analysis

• Our study discusses the selected leading companies that are the major players in the biopharmaceuticals excipients market:
• ABITEC Corp
• Signet Chemical Corporation
• Roquette Freres SA
• Sigachi Industries
• MEGGLE AG
• & Other Companies

Visiongain’s study is intended for anyone requiring commercial analyses for the biopharmaceuticals excipients market. You find data, trends, and predictions.

Buy our report today Biopharmaceuticals Excipients Market Research: Triglycerides, Esters, Mannitol, Sorbitol, Sucrose, Dextrose, Starch, Specialty Biopharmaceutical Excipients & Others.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Biopharmaceuticals Excipients Market 2020-2030


Download sample pages

Complete the form below to download your free sample pages for Biopharmaceuticals Excipients Market 2020-2030


Latest Pharma news

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

READ

Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030

The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.

07 January 2021

READ

Visiongain Publishes Inactivated Vaccines Market Report 2020-2030

Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.

07 January 2021

READ

Visiongain Publishes Human Microbiome Therapeutics Market Report 2021-2031

The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.

06 January 2021

READ

Categories

Category